JMP Group Announces Addition of Ronald Josey and John Newman as Senior Equity Research Analysts
13 November 2012 - 2:00PM
Business Wire
JMP Group Inc. (NYSE:JMP), an investment banking and alternative
asset management firm, announced today that Ronald V. Josey III and
John L. Newman have joined JMP Securities as equity research
analysts. Mr. Josey, a managing director, covers the Internet
industry, while Mr. Newman, a director, follows biotechnology. Both
analysts are based in the firm’s New York office.
“We are very pleased that Ron Josey has joined JMP,” said Mark
Lehmann, president of JMP Securities. “He is well regarded by the
institutional investment community as a result of a
technology-focused career that has spanned management consulting,
business development and equity research. His background provides
him with a multifaceted perspective on the Internet sector and its
constituent parts, including consumer Internet and e-commerce,
online advertising, social media and the mobile Internet.
“John Newman is also an important addition to our research
platform. His arrival deepens and broadens JMP’s coverage of the
biotech industry, an area that has been one of our key focuses for
many years. Working alongside Liisa Bayko and Jason Butler, John
will enhance the firm’s reputation for excellence in the sector and
its ability to serve a very specialized group of healthcare
investors.”
Prior to joining JMP Securities, Mr. Josey served as a senior
research analyst at ThinkEquity LLC, where he focused on Internet
subsectors such as e-commerce, online advertising, mobile Internet,
online video and online travel. He was previously a vice president
in equity research at Barclays Capital and its predecessor, Lehman
Brothers, with coverage of small- and mid-cap Internet stocks. Mr.
Josey also worked as a business development and marketing manager
at AOL, concentrating on product strategy and development. He began
his career as a consultant in the communications and high
technology market unit at Accenture. Mr. Josey holds an MBA from
The Robert H. Smith School of Business at University of Maryland
and a BS from Villanova University.
Prior to joining JMP Securities, Mr. Newman was a senior
research analyst covering biotechnology and specialty
pharmaceuticals at WJB Capital. He previously served in the same
capacity at Citadel Securities and Oppenheimer & Co. He began
his financial services career at Merrill Lynch, where he served in
the equity research department as part of an award-winning
biotechnology team. Beforehand, Mr. Newman was a postdoctoral
fellow in biochemistry at University of Wisconsin–Madison after
receiving his PhD in chemistry from University of Maryland. He
holds a BS from Loyola University Chicago.
About JMP Group
JMP Group Inc. is a full-service investment banking and asset
management firm that provides investment banking, sales and
trading, and equity research services to corporate and
institutional clients as well as alternative asset management
products to institutional and high-net-worth investors. JMP Group
operates through three subsidiaries: JMP Securities, Harvest
Capital Strategies and JMP Credit Advisors. For more information,
visit www.jmpg.com.
JMP (NYSE:JMP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
JMP (NYSE:JMP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024